Gilead hit with antitrust suit over HIV drugs

16-01-2020

Sarah Morgan

Gilead hit with antitrust suit over HIV drugs

Sundry Photography / Shutterstock.com

Gilead and its alleged co-conspirators Bristol-Myers Squibb, Japan Tobacco, and Johnson & Johnson have been accused of engaging in a long-running scheme to suppress competition in the market for HIV prevention therapies.


Gilead, antitrust, HIV drugs, competition, BMS, Japan Tobacco, Johnson & Johnson, antiretrovirals, generics

LSIPR